UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus

Brain, behavior, & immunity. Health, 2020-02, Vol.2, p.100018-100018, Article 100018

2020

Volltextzugriff (PDF)

Microplate Differential Calorimetric Biosensor for Ascorbic Acid Analysis in Food and Pharmaceuticals

Analytical chemistry (Washington), 2007-08, Vol.79 (16), p.6119-6127

2007

Volltextzugriff (PDF)

NIPP1-mediated Interaction of Protein Phosphatase-1 with CDC5L, a Regulator of Pre-mRNA Splicing and Mitotic Entry

The Journal of biological chemistry, 2000-08, Vol.275 (33), p.25411-25417

2000

Volltextzugriff (PDF)

The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding

Biochemical journal, 2000-12, Vol.352 Pt 3 (3), p.651-658

2000

Volltextzugriff (PDF)

Characterization of a Cloned Locust Tyramine Receptor cDNA by Functional Expression in Permanently Transformed Drosophila S2 Cells

Journal of neurochemistry, 1995-06, Vol.64 (6), p.2387-2395

1995

Volltextzugriff (PDF)

Nuclear and subnuclear targeting sequences of the protein phosphatase-1 regulator NIPP1

Journal of cell science, 2000-11, Vol.113 Pt 21 (21), p.3761-3768

2000

Volltextzugriff (PDF)

Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1

The Journal of biological chemistry, 2004-03, Vol.279 (10), p.8642-8647

2004

Volltextzugriff (PDF)

Molecular Determinants of Nuclear Protein Phosphatase-1 Regulation by NIPP-1

The Journal of biological chemistry, 1999-05, Vol.274 (20), p.14053-14061

1999

Volltextzugriff (PDF)

Baculovirus immediate early gene promoter based expression vectors for transient and stable transformation of insect cells

Insect molecular biology, 1994-01, Vol.2 (4), p.195-204

1994

Volltextzugriff (PDF)

Properties and Phosphorylation Sites of Baculovirus-expressed Nuclear Inhibitor of Protein Phosphatase-1 (NIPP-1)

The Journal of biological chemistry, 1997-12, Vol.272 (52), p.32972-32978

1997

Volltextzugriff (PDF)

Lectin binding sites during Drosophila embryogenesis

Roux's Archives of Developmental Biology, 1995-03, Vol.204 (4), p.229-243

1995

Volltextzugriff (PDF)

NIPP-1, a Nuclear Inhibitory Subunit of Protein Phosphatase-1, Has RNA-binding Properties

The Journal of biological chemistry, 1997-08, Vol.272 (35), p.22067-22071

1997

Volltextzugriff (PDF)

Mapping of the RNA-binding and endoribonuclease domains of NIPP1, a nuclear targeting subunit of protein phosphatase 1

Biochemical journal, 1999-08, Vol.342 ( Pt 1) (1), p.13-19

1999

Volltextzugriff (PDF)

Nucleotide sequence of a transactivating Bombyx mori nuclear polyhedrosis virus immediate early gene

Biochimica et biophysica acta, 1992-02, Vol.1129 (3), p.328-330

1992

Volltextzugriff (PDF)

Recombinant protein expression in insect cell systems

Belgian journal of zoology, 1997-06, Vol.127 (1)

1997

Volltextzugriff (PDF)

Baculovirus immediate early gene promoter based expression vectors for transient and stable transformation of insect cells

Insect molecular biology, 1993, Vol.2 (4), p.195-204

1993

Volltextzugriff (PDF)

Nucleotide sequence of a transactivating Bombyx mori nuclear polyhedrosis virus immediate early gene

Biochimica et biophysica acta, Protein structure and molecular enzymology, 1992-01, Vol.1129 (3), p.328-330

1992

Volltextzugriff (PDF)

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

The lancet oncology, 2021-05, Vol.22 (5), p.609-619

2021

Volltextzugriff (PDF)

1056P Real-world usage and adverse events (AE) of immune checkpoint inhibitors (ICI): A large-scale, automated, GDPR-compliant analysis of hospital records

Annals of oncology, 2024-09, Vol.35, p.S702-S703

2024

Volltextzugriff (PDF)

2184TiP Extensive cardiovascular characterization and follow-up of patients receiving immune checkpoint inhibitors: A prospective multicenter study

Annals of oncology, 2023-10, Vol.34, p.S1131-S1131

2023

Volltextzugriff (PDF)

247P Real-world evidence of immune checkpoint inhibitor treatment in lung cancer patients from a Belgian multicenter study

ESMO open, 2024-03, Vol.9, p.102709, Article 102709

2024

Volltextzugriff (PDF)

ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

Gynecologic oncology, 2020-10, Vol.159, p.221-221

2020

Volltextzugriff (PDF)

1063TiPENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1063TiP - ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

Annals of oncology, 2019-10, Vol.30, p.v433-v433

2019

Volltextzugriff (PDF)

ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

Annals of oncology, 2019-10, Vol.30, p.v433

2019

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(29)
Niederländisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus

Microplate Differential Calorimetric Biosensor for Ascorbic Acid Analysis in Food and Pharmaceuticals

NIPP1-mediated Interaction of Protein Phosphatase-1 with CDC5L, a Regulator of Pre-mRNA Splicing and Mitotic Entry

The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding

Characterization of a Cloned Locust Tyramine Receptor cDNA by Functional Expression in Permanently Transformed Drosophila S2 Cells

Nuclear and subnuclear targeting sequences of the protein phosphatase-1 regulator NIPP1

Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1

Molecular Determinants of Nuclear Protein Phosphatase-1 Regulation by NIPP-1

Baculovirus immediate early gene promoter based expression vectors for transient and stable transformation of insect cells

Properties and Phosphorylation Sites of Baculovirus-expressed Nuclear Inhibitor of Protein Phosphatase-1 (NIPP-1)

Lectin binding sites during Drosophila embryogenesis

NIPP-1, a Nuclear Inhibitory Subunit of Protein Phosphatase-1, Has RNA-binding Properties

Mapping of the RNA-binding and endoribonuclease domains of NIPP1, a nuclear targeting subunit of protein phosphatase 1

Nucleotide sequence of a transactivating Bombyx mori nuclear polyhedrosis virus immediate early gene

Recombinant protein expression in insect cell systems

Baculovirus immediate early gene promoter based expression vectors for transient and stable transformation of insect cells

Nucleotide sequence of a transactivating Bombyx mori nuclear polyhedrosis virus immediate early gene

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

1056P Real-world usage and adverse events (AE) of immune checkpoint inhibitors (ICI): A large-scale, automated, GDPR-compliant analysis of hospital records

2184TiP Extensive cardiovascular characterization and follow-up of patients receiving immune checkpoint inhibitors: A prospective multicenter study

247P Real-world evidence of immune checkpoint inhibitor treatment in lung cancer patients from a Belgian multicenter study

ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

1063TiPENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

1063TiP - ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

Suchergebnisse filtern